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Abstract
Background: Cephalic vein (CV) cutdown approach for chronic indwelling central venous access
device (CICVAD) placement has previously been shown to be technically feasible in 82% of cancer
patients. No data are available as to the potential utilization of external jugular vein (EJV) cutdown
approach in cancer patients when CV cutdown approach is not technically feasible.
Patients and methods: One hundred and twenty consecutive cancer patients were taken to the
operating room with the intention of placing a CICVAD. All patients were first subjected to
attempted CV cutdown approach. If CV cutdown approach was unsuccessful and there were no
contraindications to establishing central venous access in the ipsilateral neck region, an ipsilateral
EJV cutdown approach was attempted.
Results: Ninety-five cancer patients (79%) underwent CICVAD placement via CV cutdown. Of
those 25 patients in which CV cutdown was not technically feasible, 7 had a contraindication to
establishing central venous access in the ipsilateral neck region and a CICVAD was placed via the
ipsilateral subclavian vein percutaneous approach. Of those remaining 18 patients in which CV
cutdown approach was not technically feasible, 17 (94%) underwent CICVAD placement via
ipsilateral EJV cutdown approach. Combined success of the CV and EJV cutdown approaches,
excluding those 7 patients with a contraindication to central venous access in the ipsilateral neck
region, was greater than 99%.
Conclusions: Venous cutdown approaches for CICVAD placement are viable alternatives to
subclavian vein percutaneous approach in cancer patients. EJV cutdown approach appears to be a
highly successful and safe alternative route when CV cutdown approach is not technically feasible
and may be considered a potentially useful primary route for CICVAD placement in cancer
patients.
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Introduction
The vast majority of chronic indwelling central venous
access devices (CICVAD) are placed in cancer patients by
the subclavian vein percutaneous approach [1]. Venous
cutdown approaches can be useful alternatives; however,
they appear to be infrequently utilized. The cephalic vein
(CV) cutdown approach has been previously shown to be
technically feasible in 82% of cancer patients [2]. Like-
wise, the external jugular vein (EJV) cutdown approach
has been previously shown to be technically feasible in
88% of cancer patients [3]. Although the EJV cutdown
approach for central venous access is well described in the
literature [3-8], there is no data available which specifi-
cally addresses the question of the potential utilization of
EJV cutdown approach for CICVAD placement in cancer
patients when the CV cutdown approach is not technically
feasible. This question is specifically addressed in the
present study.
Patients and methods
Between March 27, 2000 and June 25, 2001, 120 consec-
utive cancer patients evaluated for placement of a CIC-
VAD were taken to the operating room by a single surgeon
(S.P.P.) with the intention of placing a CICVAD. Two
types CICVAD were used: BardPort® titanium implanted
single lumen (9.6 French) ports (Bard Access Systems, Salt
Lake City, Utah) or Leonard® (10 French)/Hickman® (12
French) dual-lumen tunneled central venous catheters
(Bard Access Systems, Salt Lake City, Utah). Each CICVAD
described above was equipped with a radiopaque silicone
catheter.
We have previous reported that preoperative venous
duplex ultrasound to the upper extremity veins and cen-
tral veins can be useful in demonstrating residual abnor-
malities in upper extremity venous anatomy (specifically
to the brachial vein, axillary vein, subclavian vein and
internal jugular vein) in patients with a history of previous
upper extremity central venous access and a documented
history of a previous upper extremity deep venous throm-
bosis [9]. However, this is not the case for assessment of
the innominate vein, and superior vena cava. Therefore,
all such patients with a history of previous upper extrem-
ity central venous access and a documented history of a
previous upper extremity deep venous thrombosis under-
went preoperative bilateral venous duplex ultrasound to
the upper extremity and accessible central veins to rule out
such venous abnormalities that could potentially pre-
clude successful CICVAD placement. If such a venous
abnormality was identified on preoperative venous
duplex ultrasound, the contralateral side was selected for
placement of the CICVAD.
Each patient brought to the operating room was placed on
the operating room table in a supine position with a
rolled sheet placed vertically in the small of the patient's
back to rotate the patient's shoulders posteriorly. The pro-
cedure was generally performed under monitored intrave-
nous sedation, utilizing local anesthetic. However, if the
patient requires general anesthesia for other concurrent
surgical procedures or requested general anesthesia, then
the procedure was performed under general anesthesia.
The entire chest and neck of the patient were bilaterally
prepped and draped in a sterile fashion. All patients were
first subjected to an attempted CV cutdown approach at
the deltopectoral groove, using the method previously
described [2].
If the CV cutdown approach was unsuccessful and there
were no contraindications to establishing central venous
access in the ipsilateral neck region, an ipsilateral EJV cut-
down approach was attempted. The patient's head was
turned slightly to the contralateral side. In this fashion,
the EJV was then generally easily transcutaneously identi-
fied. However, if necessary, the patient was briefly placed
into Trendelenburg position to transcutaneously identify
the course of the EJV. The course of the EJV was marked on
the skin with a marking pen and the patient was taken out
of Trendelenburg position. Then, a longitudinal 1.5 cm
skin incision was made overlying the EJV in the mid neck
region. The EJV was circumferentially dissected out and
two separate 2-0 silk sutures were then placed around the
EJV, with one 2-0 silk suture placed proximal and one 2-0
silk suture placed distally around the EJV. The 2-0 silk
suture placed distally around the EJV was then securely
tied down. The EJV was then partially transected with a
#11 blade in a transverse fashion along its exposed mid-
portion. Back-bleeding from the proximal end of the EJV
was controlled by applying mild traction to the proxi-
mally placed 2-0 silk suture. With the assistance of a vein-
pick, the catheter was then passed into the lumen of the
partially transected EJV and directed centrally. Using real-
time fluoroscopic guidance, the catheter was then
advanced centrally towards the subclavian vein, the
innominate vein and the superior vena cava. The tip of the
catheter was positioned in the superior vena cava, usually
at the junction of the superior vena cava and right atrium.
Once correctly positioned, the proximally placed 2-0 silk
suture around the catheter and the proximal end of the
EJV was then tied down around the catheter in a non-con-
stricting fashion to prevent back-bleeding and catheter
migration. The catheter was tunneled from the mid neck
incision and over the clavicle to the ipsilateral infraclavic-
ular incision using a tendon passer. The techniques for
positioning/securing, testing function, and heparinizing
the implanted port or tunneled catheter were performed
using the method previously described [2].
If the ipsilateral EJV cutdown approach was unsuccessful
or if there was a contraindication to establishing centralWorld Journal of Surgical Oncology 2004, 2 http://www.wjso.com/content/2/1/7
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venous access in the ipsilateral neck region, an ipsilateral
subclavian vein percutaneous approach with the patient
in Trendelenburg position was attempted.
For all three approaches to establishing central venous
access, intraoperative venography was selectively utilized
for difficult cases of central venous access placement and
has been previously described [9]. However, during the
study period, intraoperative ultrasound was not available
for difficult cases. For all three approaches to establishing
central venous access, the patients were monitored for
immediate postoperative complications.
All patient data were entered into a prospectively main-
tained central venous access database by the operating
surgeon. All analyses were performed utilizing the statisti-
cal software program SPSS for Windows© (version 11.0,
SPSS, Incorporated, Chicago, Illinois). Since all of the
patients undergoing either the EJV cutdown approach or
the subclavian vein percutaneous approach had also first
undergone an unsuccessful attempt at the CV cutdown
approach, no direct comparative analysis of the results
from the CV cutdown approach, the EJV cutdown
approach, or the subclavian vein percutaneous approach
was undertaken.
Results
Of the 120 consecutive patients taken to the operating
room with the intention of placing a CICVAD, median
patient age was 53 years (range 23–81), of which 72 were
females and 48 were males. Thirty-one patients had breast
cancer, 25 had gastrointestinal malignancies, 16 had
leukemia, 15 had lymphoma, 8 had multiple myeloma, 7
had head/neck malignancies, 4 had lung cancer, and 14
had other malignancies. The procedure was performed
utilizing monitored intravenous sedation and local anes-
thetic in 63 patients. Thirty-seven patients requested gen-
eral anesthesia for the procedure and 18 patients required
general anesthesia for the performance of another concur-
rent surgical procedures. Only 2 patient required conver-
sion from monitored intravenous sedation to general
anesthesia during the procedure. Eighty, BardPort® 9.6
French implanted ports, 31, Leonard® 10 French tunneled
catheters, and 9 Hickman® 12 French tunneled catheters
were placed. Median operating time for CICVAD place-
ment for all the 120 consecutive patients was 48 minutes
(range 23–210).
Of the 120 consecutive patients taken to the operating
room with the intention of placing a CICVAD, 95 patients
(79%) underwent successful CICVAD placement via the
CV cutdown approach and 25 patients (21%) did not.
Median operating time for those 95 patients undergoing a
successful CV cutdown approach was 45 minutes (range
23–84). Of the 25 patients in whom successful CICVAD
placement via the CV cutdown approach was not techni-
cally feasible, 17 patients had too small CV thus making
the catheter placement difficult and 8 patients had no
detectable CV. Likewise, of those 25 patients in whom
successful CICVAD placement via the CV cutdown
approach was not technically feasible, 7 patients had a
contraindication to establishing central venous access in
the ipsilateral neck region. This included 2 patients with a
history of carotid artery surgery, 2 with a newly diagnosed
esophageal cancer requiring neoadjuvant chemotherapy,
1 with a history of neck surgery for a head/neck malig-
nancy, 1 with a neck mass associated with a newly diag-
nosed head/neck malignancy requiring neoadjuvant
chemotherapy, and 1 with adenopathy of the neck associ-
ated with metastatic breast cancer.
Of those 18 patients in whom successful CICVAD place-
ment via the CV cutdown approach was not technically
feasible and in whom there was no contraindication to
establishing central venous access in the ipsilateral neck
region, 17 (94%) underwent successful CICVAD place-
ment via the ipsilateral EJV cutdown approach. Median
operating time for those 17 patients was 68 minutes
(range 44–125). The single patient who failed both the CV
cutdown approach and ipsilateral EVJ cutdown approach
also failed the ipsilateral subclavian vein percutaneous
approach. In this case, a CICVAD was eventually placed
during the same operative setting by way of a contralateral
CV cutdown approach.
All of the 7 patients, in whom successful CICVAD place-
ment via the CV cutdown approach was not technically
feasible and in whom there was a contraindication to
establishing central venous access in the ipsilateral neck
region, successfully underwent CICVAD placement via the
ipsilateral subclavian vein percutaneous approach.
Median total operating time for those 7 patients was 68
minutes (range 34–210).
The combined success the CV cutdown approach and the
ipsilateral EJV cutdown approach for CICVAD placement,
including those 7 patients with a contraindication to cen-
tral venous access in the ipsilateral neck region after
unsuccessful CV cutdown, was 93% (112 of 120 patients).
The combined success the CV cutdown approach and the
ipsilateral EJV cutdown approach for CICVAD placement,
excluding those 7 patients with a contraindication to cen-
tral venous access in the ipsilateral neck region after
unsuccessful CV cutdown, was greater than 99% (112 of
113 patients).
No instances of immediate postoperative complications,
such as pneumothorax, hemothorax, or injury to great
vessels, was seen in the group of patients undergoing suc-
cessful CICVAD placement by way of the CV cutdownWorld Journal of Surgical Oncology 2004, 2 http://www.wjso.com/content/2/1/7
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approach, by way of the ipsilateral EJV cutdown approach
after unsuccessful CV cutdown approach, or by way of the
ipsilateral subclavian vein percutaneous approach after
unsuccessful CV cutdown approach. However, a single
case of postoperative ipsilateral pneumothorax was recog-
nized intraoperatively in a patient who failed the ipsilat-
eral CV cutdown approach, failed the ipsilateral EVJ
cutdown approach, and failed the ipsilateral subclavian
vein percutaneous approach prior to successful CICVAD
placement by way of the contralateral CV cutdown
approach.
Discussion
Although most CICVAD are placed in cancer patients by
the subclavian vein percutaneous approach [1], venous
cutdown approaches can be useful alternatives. In the
present study, we specifically address the question of the
potential utilization of EJV cutdown approach for CIC-
VAD placement when the CV cutdown approach is not
technically feasible.
In the present study, the CV cutdown approach alone was
successful in 79% of cases. These results for the CV cut-
down approach are virtually identical to those previously
published [2,10]. Additionally, the ipsilateral EJV cut-
down approach, after an unsuccessful CV cutdown
approach, was successful in 94% (17/18) of cases. These
results for the EJV cutdown approach after an unsuccessful
CV cutdown approach are also virtually identical to those
previously published for utilization of the EJV approach
alone [3]. Finally, the resultant combined success of the
CV cutdown approach and of the ipsilateral EJV cutdown
approach, excluding those patients with a contraindica-
tion to central venous access in the ipsilateral neck region
after unsuccessful CV cutdown approach, was greater than
99% (112/113). Such an impressive success rate for
venous cutdown approaches could virtually eliminates
the need for consideration of the subclavian vein percuta-
neous approach for CICVAD placement in appropriately
selected cancer patients.
Previous studies have shown that the subclavian vein per-
cutaneous approach for CICVAD placement has a well-
documented risk of pneumothorax in approximately 1%
to 4% of cases [11-14]. In contrast, previous studies have
shown an absence of immediate perioperative complica-
tions, including pneumothorax, for both the CV cutdown
approach [2,10,15-18] and the EJV cutdown approach
[3,16]. Further confirmation of this is demonstrated in the
current report in which no single instance of an immedi-
ate postoperative complication, such as pneumothorax,
hemothorax, or injury to great vessels, was seen in either
group of patients undergoing successful CICVAD place-
ment by the CV cutdown approach alone or successful
CICVAD placement by subsequent ipsilateral EJV cut-
down approach after an unsuccessful CV cutdown
approach. The lack of such complications with venous
cutdown approaches does add further support to the uti-
lization of venous cutdown approaches for CICVAD
placement in cancer patients, however, the current report
was not designed to specifically address and compare the
risk of immediate postoperative complications between
venous cutdown approaches and the subclavian vein per-
cutaneous approach.
It is the author's opinion that several general statements
can be made with regards to CICVAD placement by way
of the CV and EJV cutdown approaches in cancer patients.
First, utilization of a venous cutdown approach (whether
it be by way of the CV or the EJV), as compared to the sub-
clavian vein percutaneous approach, appears to give a uni-
formly high success of catheter placement and appears to
give considerable perioperative safety to CICVAD place-
ment in cancer patients. Second, the EJV cutdown
approach itself appears to be a highly successful and safe
alternative route for CICVAD placement in cancer patients
when the CV cutdown approach is not technically feasi-
ble. Third, the EJV cutdown approach may be considered
as a potentially useful primary route for successful CIC-
VAD placement in cancer patients in place of considera-
tion of the CV cutdown approach or in place of the
subclavian vein percutaneous approach. In the future, it is
this author's hope that such information may encourage
others to give consideration to and to broaden their utili-
zation of venous cutdown approaches to CICVAD place-
ment in cancer patients. However, randomized controlled
trials comparing various methods of venous access device
placement are needed to answer some of the unresolved
issues.
List of abbreviations
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